Effect of lactoferrin on viceral fat suppression in patients with chronic liver disease; a randomized, double blind, placebo-controlled, clinical trial
Phase 2
- Conditions
- Chronic liver disease
- Registration Number
- JPRN-UMIN000004174
- Lead Sponsor
- Yokohama City University Medical Center Gastroenterological Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 34
Inclusion Criteria
Not provided
Exclusion Criteria
1.Subjects who have already treated with anti-dyslipidemic agent 2.Sublects during pregnancy, feeding, intimation of pregnancy or intended pregnancy 3.Subjects who have already treated with interferon and ribavirin 4.Subjects who have already treated with steroids, immunosuppressive agent, and antitumor agent
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The change in viceral fat (measured by helical CT scan)
- Secondary Outcome Measures
Name Time Method 1)The change in serum viral genome 2)The change in serum lipid or lipid marker levels 3)The change in serum ALT